{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:31:12Z","timestamp":1793640672192,"version":"4.5.1"},"reference-count":27,"publisher":null,"issue":"11","license":[{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/lib.ossn.ru\/jour\/about\/editorialPolicies#openAccessPolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kardiologiia"],"abstract":"<jats:p>\n                    <jats:italic>Aim<\/jats:italic>\n                    \u00a0 \u00a0To identify possible predictors of tachycardia-induced cardiomyopathy (TICMP) in patients with newly developed decompensated chronic heart failure (CHF) of nonischemic origin with reduced left ventricular ejection fraction (LV EF) and with persistent atrial tachyarrhythmias.\u00a0\n                    <jats:italic>Material and methods<\/jats:italic>\n                    \u00a0 \u00a0This study included 88 patients with newly developed decompensated CHF of nonischemic origin with reduced LV EF and persistent atrial tachyarrhythmias. Resting 12-lead electrocardiography (EGC) and transthoracic echocardiography (EchoCG) were performed upon admission and following the electrical impulse therapy for all patients. Also, 24-h ECG monitoring was performed to confirm sinus rhythm stability. After recovery of sinus rhythm, outpatient monitoring was performed for three months, including repeated EchoCG to evaluate the dynamics of heart chamber dimensions and LV EF.\u00a0\n                    <jats:italic>Results<\/jats:italic>\n                    \u00a0 \u00a0The patients were divided into two groups based on the increase in LV EF: 68 responders (TICMP patients with a LV EF increase by &gt;10%) and 20 non-responders (patients with an increase in LV EF by &lt;10% during 3 months following the sinus rhythm recovery). According to results of the baseline EchoCG, LV EF did not significantly differ in the two subgroups (TICMP, 40\u00b18.3\u200a%, 18\u201350\u200a% and non-responders, 38.55\u00b17.9\u200a%, 24\u201350\u200a%); moreover, the incidence of cases with LV EF &lt;30% did not differ either (9 patients TICMP and 2 non-responders, \u0440=1.0). TICMP patients compared to non-responders, had significantly smaller left atrial dimensions (4.53\u00b11.14 (2\u20137)\u2008cm and 5.68\u00b11.41 (4\u20138)\u2008cm, \u0440=0.034; 80.8\u00b128.9 (27\u2013215)\u2008ml and 117.8\u00b141.3 (46\u2013230)\u2008ml, \u0440=0.03, respectively) and left ventricular end-systolic volume (ESV) (67.7\u00b133.1 (29\u2013140)\u2008ml and 104.5\u00b144.7 (26\u2013172)\u2008ml, \u0440=0.02, respectively). The effect of major EchoCG parameters on the probability of TICMP development was assessed by one-factor and multifactor regression analyses with adjustments for age and sex. The probability of TICMP increased with the following baseline EchoCG parameters: end-diastolic volume (EDV) &lt;174\u2008ml [odd ratio (OR), 0.115, 95\u200a% confidence interval (CI): 0.035\u20130.371], ESV &lt;127\u2008ml [OR, 0.034, 95\u200a% CI: 0.007\u20130.181], left atrial volume &lt;96\u2008ml [OR, 0.08\u200a, 95\u200a% CI: 0.023\u20130.274], right ventricular dimension &lt;4\u2008cm [OR, 0.042\u200a, 95\u200a% CI: 0.005\u20130.389].\n                    <jats:italic>Conclusion<\/jats:italic>\n                    \u00a0 \u00a0Among patients with newly developed decompensation of CHF with reduced LV EF of non-ischemic origin and persistent atrial arrhythmias, TICMP was detected in 72\u200a% of patients. The probability of TICMP did not depend on baseline EF and duration of arrhythmias, but increased with the following baseline EchoCG parameters: EDV&lt; 174\u2008ml, ESV&lt; 127\u2008ml, left atrial volume &lt;96\u2008ml, right ventricular dimension &lt;4\u2008cm. The multifactorial analysis showed that a right atrial volume &lt;96 ml is an independent predictor for the development of TICMP.\n                  <\/jats:p>","DOI":"10.18087\/cardio.2022.11.n2262","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T14:51:43Z","timestamp":1671115903000},"page":"56-62","source":"Crossref","is-referenced-by-count":5,"title":["Predictors of tachycardia-induced cardiomyopathy in patients with first-time decompensation of chro\u00adnic heart failure with reduced left ventricular ejection fraction of nonischemic etiology and persistent atrial tachyarrhythmia"],"prefix":"10.68900","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2174-3183","authenticated-orcid":true,"given":"O. S.","family":"Orlov","sequence":"first","affiliation":[{"name":"Sechenov First Moscow State Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1637-4720","authenticated-orcid":true,"given":"A.","family":"Asfour","sequence":"additional","affiliation":[{"name":"Sechenov First Moscow State Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8209-2791","authenticated-orcid":true,"given":"A. A.","family":"Bogdanova","sequence":"additional","affiliation":[{"name":"Sechenov First Moscow State Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7034-8382","authenticated-orcid":true,"given":"D. Yu.","family":"Shchekochikhin","sequence":"additional","affiliation":[{"name":"Sechenov First Moscow State Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3604-4975","authenticated-orcid":true,"given":"A. S.","family":"Akselrod","sequence":"additional","affiliation":[{"name":"Sechenov First Moscow State Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5602-8809","authenticated-orcid":true,"given":"A. P.","family":"Nesterov","sequence":"additional","affiliation":[{"name":"Pirogov Russian Research Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0276-7374","authenticated-orcid":true,"given":"D. A.","family":"Andreev","sequence":"additional","affiliation":[{"name":"Sechenov First Moscow State Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":null,"published-online":{"date-parts":[[2022,11,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Gopinathannair R, Etheridge SP, Marchlinski FE, Spinale FG, Lakkireddy D, Olshansky B. Arrhythmia-Induced Cardiomyopathies: Mechanisms, recognition, and management. Journal of the American College of Cardiology. 2015;66(15):1714\u201328. DOI: 10.1016\/j.jacc.2015.08.038","DOI":"10.1016\/j.jacc.2015.08.038"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Russian Journal of Cardiology. 2021;26(9):234\u2013329. DOI: 10.15829\/1560-4071-021-4701","DOI":"10.15829\/1560-4071-2021-4701"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. European Heart Journal. 2020;42(5):373\u2013498. DOI: 10.1093\/eurheartj\/ehaa612","DOI":"10.1093\/eurheartj\/ehab648"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Stronati G, Guerra F, Urbinati A, Ciliberti G, Cipolletta L, Capucci A. Tachycardiomyopathy in Patients without Underlying Structural Heart Disease. Journal of Clinical Medicine. 2019;8(9):1411. DOI: 10.3390\/jcm8091411","DOI":"10.3390\/jcm8091411"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Dandamudi G, Rampurwala AY, Mahenthiran J, Miller JM, Das MK. Persistent left ventricular dilatation in tachycardia-induced cardiomyopathy patients after appropriate treatment and normalization of ejection fraction. Heart Rhythm. 2008;5(8):1111\u20134. DOI: 10.1016\/j.hrthm.2008.04.023","DOI":"10.1016\/j.hrthm.2008.04.023"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Medi C, Kalman JM, Haqqani H, Vohra JK, Morton JB, Sparks PB et al. Tachycardia-Mediated Cardiomyopathy Secondary to Focal Atrial Tachycardia: Long-term outcome after catheter ablation. Journal of the American College of Cardiology. 2009;53(19):1791\u20137. DOI: 10.1016\/j.jacc.2009.02.014","DOI":"10.1016\/j.jacc.2009.02.014"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Fujino T, Yamashita T, Suzuki S, Sugiyma H, Sagara K, Sawada H et al. Characteristics of Congestive Heart Failure Accompanied by Atrial Fibrillation With Special Reference to Tachycardia-Induced Cardiomyopathy. Circulation Journal. 2007;71(6):936\u201340. DOI: 10.1253\/circj.71.936","DOI":"10.1253\/circj.71.936"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Jeong Y-H, Choi K-J, Song J-M, Hwang E-S, Park K-M, Nam G-B et al. Diagnostic Approach and Treatment Strategy in Tachycardia-induced Cardiomyopathy. Clinical Cardiology. 2008;31(4):172\u20138. DOI: 10.1002\/clc.20161","DOI":"10.1002\/clc.20161"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Nia AM, Gassanov N, Dahlem KM, Caglayan E, Hellmich M, Erdmann E et al. Diagnostic accuracy of NT-proBNP ratio (BNP-R) for early diagnosis of tachycardia-mediated cardiomyopathy: a pilot study. Clinical Research in Cardiology. 2011;100(10):887\u201396. DOI: 10.1007\/s00392-011-0319-y","DOI":"10.1007\/s00392-011-0319-y"},{"key":"ref10","unstructured":"Bubeshka D.A., Snezhitskiy V.A. On the mechanism of tachycardiainduced cardiomyopathy in patients with atrial fibrillation. Grodno State Medical University Journal. 2015;2(50):24\u20139."},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography. 2015;28(1):1-39.e14. DOI: 10.1016\/j.echo.2014.10.003","DOI":"10.1016\/j.echo.2014.10.003"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K et al. Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography. Journal of the American Society of Echocardiography. 2010;23(7):685\u2013713. DOI: 10.1016\/j.echo.2010.05.010","DOI":"10.1016\/j.echo.2010.05.010"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Zoghbi W. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and doppler echocardiography. Journal of the American Society of Echocardiography. 2003;16(7):777\u2013802. DOI: 10.1016\/S0894-7317(03)00335-3","DOI":"10.1016\/S0894-7317(03)00335-3"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Hemmelgarn BR, Manns BJ, Quan H, Ghali WA. Adapting the charlson comorbidity index for use in patients with ESRD. American Journal of Kidney Diseases. 2003;42(1):125\u201332. DOI: 10.1016\/S0272-6386(03)00415-3","DOI":"10.1016\/S0272-6386(03)00415-3"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Cattran DC, Feehally J, Cook HT, Liu ZH, Fervenza F, Mezzano SA et al. Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney International Supplements. 2012;2(2):139\u2013274. DOI: 10.1038\/kisup.2012.9","DOI":"10.1038\/kisup.2012.9"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Berdibekov B.Sh., Aleksandrova S.A., Mrikaev D.V., Golukhova E.Z. Premature ventricular contraction-induced cardiomyopathy. Creative Cardiology. 2020;14(2):125\u201337. DOI: 10.24022\/1997-3187-2020-14-2-125-137","DOI":"10.24022\/1997-3187-2020-14-2-125-137"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Cruz FES, Cheriex EC, Smeets JLRM, Atie J, Peres AK, Penn OCKM et al. Reversibility of tachycardia-induced cardiomyopathy after cure of incessant supraventricular tachycardia. Journal of the American College of Cardiology. 1990;16(3):739\u201344. DOI: 10.1016\/0735-1097(90)90368-Y","DOI":"10.1016\/0735-1097(90)90368-Y"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Wilson JR, Douglas P, Hickey WF, Lanoce V, Ferraro N, Muhammad A et al. Experimental congestive heart failure produced by rapid ventricular pacing in the dog: cardiac effects. Circulation. 1987;75(4):857\u201367. DOI: 10.1161\/01.CIR.75.4.857","DOI":"10.1161\/01.CIR.75.4.857"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Spinale FG, Hendrick DA, Crawford FA, Smith AC, Hamada Y, Carabello BA. Chronic supraventricular tachycardia causes ventricular dysfunction and subendocardial injury in swine. American Journal of Physiology. 1990;259(1):H218\u201329. DOI: 10.1152\/ajpheart.1990.259.1.H218","DOI":"10.1152\/ajpheart.1990.259.1.H218"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Shinbane JS, Wood MA, Jensen DN, Ellenbogen KA, Fitzpatrick AP, Scheinman MM. Tachycardia-Induced Cardiomyopathy: A Review of Animal Models and Clinical Studies. Journal of the American College of Cardiology. 1997;29(4):709\u201315. DOI: 10.1016\/S0735-1097(96)00592-X","DOI":"10.1016\/S0735-1097(96)00592-X"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Chow E, Woodard JC, Farrar DJ. Rapid ventricular pacing in pigs: an experimental model of congestive heart failure. American Journal of Physiology. 1990;258(5):H1603\u20135. DOI: 10.1152\/ajpheart.1990.258.5.H1603","DOI":"10.1152\/ajpheart.1990.258.5.H1603"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Batul SA, Gopinathannair R. Atrial Fibrillation in Heart Failure: a Therapeutic Challenge of Our Times. Korean Circulation Journal. 2017;47(5):644\u201362. DOI: 10.4070\/kcj.2017.0040","DOI":"10.4070\/kcj.2017.0040"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Atabegashvili M.R., Shchekochikhin D.Yu., Gromyko G.A., Pershina E.S., Bogdanova A.A., Nesterov A.P. et al. Tachicardia-induced cardiomyopathy. Case report. Therapeutic Archive. 2021;93(4):465\u2013 9. DOI: 10.26442\/00403660.2021.04.200803","DOI":"10.26442\/00403660.2021.04.200803"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Mueller KAL, Heinzmann D, Klingel K, Fallier-Becker P, Kandolf R, Kilias A et al. Histopathological and Immunological Characteristics of Tachycardia-Induced Cardiomyopathy. Journal of the American College of Cardiology. 2017;69(17):2160\u201372. DOI: 10.1016\/j.jacc.2017.02.049","DOI":"10.1016\/j.jacc.2017.02.049"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Bozkurt B, Colvin M, Cook J, Cooper LT, Deswal A, Fonarow GC et al. Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association. Circulation. 2016;134(23):e579\u2013646. DOI: 10.1161\/CIR.0000000000000455","DOI":"10.1161\/CIR.0000000000000455"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Oka S, Kai T, Hoshino K, Watanabe K, Nakamura J, Abe M et al. Rate Versus Rhythm Control in Tachycardia-Induced Cardiomyopathy Patients with Persistent Atrial Flutter. International Heart Journal. 2021;62(1):119\u201326. DOI: 10.1536\/ihj.20-266","DOI":"10.1536\/ihj.20-266"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Fenelon G, Wijns W, Andries E, Brugada P. Tachycardiomyopathy: Mechanisms and Clinical Implications. Pacing and Clinical Electrophysiology. 1996;19(1):95\u2013106. DOI: 10.1111\/j.1540-8159.1996.tb04796.x","DOI":"10.1111\/j.1540-8159.1996.tb04796.x"}],"container-title":["Kardiologiia"],"original-title":[],"link":[{"URL":"https:\/\/lib.ossn.ru\/jour\/article\/viewFile\/2262\/1306","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:16:24Z","timestamp":1793639784000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardio.elpub.ru\/jour\/article\/view\/2262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,30]]},"references-count":27,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11,30]]}},"URL":"https:\/\/doi.org\/10.18087\/cardio.2022.11.n2262","relation":{},"ISSN":["2412-5660","0022-9040"],"issn-type":[{"value":"2412-5660","type":"electronic"},{"value":"0022-9040","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,30]]}}}